Entries by sgmo-adm-bb

SSMO statement on Lunsumio

The SSMO takes note of this unprecedented incident with concern. Although follicular lymphoma is a relatively rare form of cancer affecting relatively few patients, it nevertheless raises an important question: […]

Swiss Patient Access Program (SPAP)

The SSMO launched the Swiss Patient Access Program (SPAP) in 2023, as a follow-up project to the SPAP pilot. SPAP aims to: Avoid/reduce cases of hardship in processing Art. 71 […]